DR. SAURIN MEHTA MD NPI 1245394295

NPI Details

DR. Saurin Mehta, MD is a specialist in Wyomissing, PA with 23 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. DR. Saurin Mehta, MD NPI is 1245394295. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: TEMPLE UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2003

The provider's business location address is:

2760 CENTURY BLVD
WYOMISSING, PA
ZIP 19610-359
Phone: (610) 375-4251
Fax: (610) 375-6210

The NPI 1245394295 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Vitamin d-3 level (HCPCS:82306)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose (HCPCS:J7324)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Aspiration and/or injection of fluid from small joint using ultrasound guidance (HCPCS:20604)
• X-ray of hand, 2 views (HCPCS:73120)
• Injection into tendon or ligament (HCPCS:20550)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Calcium level, total (HCPCS:82310)
• Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose (HCPCS:J7323)
• Blood creatinine level (HCPCS:82565)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• X-ray of knee, 1-2 views (HCPCS:73560)
• X-ray of lower and sacral spine, minimum of 4 views (HCPCS:72110)
• Liver enzyme (sgot), level (HCPCS:84450)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Albumin (protein) level (HCPCS:82040)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Total protein level, blood (HCPCS:84155)
• Aspiration and/or injection of fluid from medium joint using ultrasound guidance (HCPCS:20606)
• X-ray of foot, 2 views (HCPCS:73620)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Rheumatoid factor level (HCPCS:86431)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Injection of trigger points, 1-2 muscles (HCPCS:20552)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• X-ray of middle spine, 2 views (HCPCS:72070)
• X-ray of knee, 3 views (HCPCS:73562)
• X-ray of upper spine, 4-5 views (HCPCS:72050)
• X-ray of both knees while standing (HCPCS:73565)
• X-ray of pelvis, 1-2 views (HCPCS:72170)
• Screening test for autoimmune disorder (HCPCS:86038)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Measurement of dna antibody, single stranded (HCPCS:86226)

The enumeration date for this NPI number is 12/21/2006 and was last updated on 7/12/2010.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.